| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 12/27/1991 | EP0462292A1 Salt eliminant composition |
| 12/26/1991 | WO1991019419A1 Pasteurella multocida toxoid vaccines |
| 12/25/1991 | WO1992000296A1 Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands |
| 12/25/1991 | CA2084288A1 Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands |
| 12/17/1991 | US5073385 Aluminum oxyhydroxide sulfate |
| 12/14/1991 | WO1991019478A1 Anti-actinic agent |
| 12/14/1991 | CA2059641A1 Light protection compound |
| 12/03/1991 | US5070104 Methods of chelating metal and novel compositions therefor |
| 11/27/1991 | CN1014887B Process for preparation of amides, pharmacologically active compound |
| 11/20/1991 | CN1014790B Process for preparing novel benzoxazol-and benzothiazolamine derivatives and their use |
| 11/19/1991 | US5066644 Derivatives of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it |
| 11/14/1991 | WO1991017151A1 New pharmacologically active catechol derivatives |
| 11/12/1991 | US5064819 Substituted propane-phosphinic acid compounds |
| 10/31/1991 | WO1991016315A1 5-benzyl barbiturate derivatives |
| 10/30/1991 | EP0453507A1 Chelating agent derivatives |
| 10/29/1991 | US5061477 Use of cobalt to enhance urinary copper excretion |
| 10/22/1991 | US5059594 Phytic acid compositions |
| 10/22/1991 | CA1291043C Composition and method for reducing acetaldehyde toxicity |
| 10/02/1991 | EP0449764A2 A method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptor antagonist |
| 10/02/1991 | EP0449247A2 Pharmaceutical composition containing Galanthamine for treating alcoholism |
| 09/24/1991 | US5051524 Substituted propane-phosphinic acid compounds |
| 09/19/1991 | WO1991013629A1 Use of lactoferrin to counter the toxic effects of endotoxins |
| 09/18/1991 | EP0447324A1 2,4-Pyrimidinedione derivatives and medicines containing them |
| 09/17/1991 | US5049679 Carboxamide derivatives |
| 09/17/1991 | US5049576 Carboxamide derivatives |
| 09/16/1991 | CA2038198A1 2,4-pyrimidinedione derivatives and pharmaceutical compositions containing them |
| 09/04/1991 | EP0444899A2 Catechol derivatives, their physiologically acceptable salts, esters and their use in the treatment of tissue damage induced by lipid peroxidation |
| 08/28/1991 | EP0442878A1 Derivatives of tryptophan as cck antagonists |
| 08/23/1991 | CA2036774A1 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptorantagonist or a |
| 08/13/1991 | US5039666 Using 7-oxoalkyl-1,3-dialkyl xanthine compound |
| 08/08/1991 | WO1991011189A1 USE OF AN α-TOCOPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED |
| 08/07/1991 | EP0440325A2 Methods of chelating metal and novel compositions therefor |
| 08/07/1991 | EP0180581B1 Drug preparations of reduced toxicity |
| 07/31/1991 | EP0438903A2 Treatment of poisoning and compositions for use therein |
| 07/20/1991 | WO1991010669A1 Chelating compounds |
| 07/20/1991 | CA2072080A1 Chelating compounds |
| 07/17/1991 | WO1991010655A1 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism |
| 07/17/1991 | CA2048627A1 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism |
| 07/16/1991 | CA1286224C Use of human growth hormone for the treatment of intoxicated individuals |
| 07/10/1991 | WO1991010436A1 Salt eliminant composition |
| 07/10/1991 | CA2048614A1 Salt excretion-promoting composition |
| 07/02/1991 | US5028428 Cola Nitida Extract, Cosmetics |
| 06/26/1991 | EP0434625A2 IGF-I for treating adverse effect of steroid therapy |
| 06/26/1991 | EP0434470A2 Protection against chemically-induced kidney damage by methimazole |
| 06/13/1991 | WO1991000729A3 Bis-dioxopiperazines, and their use as protecting agents |
| 06/11/1991 | US5023073 Method of combating flupropadine poisoning using phenothiazines |
| 06/04/1991 | US5021448 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist |
| 05/29/1991 | EP0428636A1 Use of interleukin 2 to treat endotoxinemia. |
| 05/28/1991 | US5019566 Method of treating inflammation with inositol triphosphate |
| 05/22/1991 | CN1051554A Indenoindole compounds ii |
| 05/21/1991 | US5017371 Method for reducing side effects of cancer therapy |
| 05/15/1991 | EP0427518A1 NMDA-Blocking compounds, pharmaceutical compositions, their preparation and use |
| 05/15/1991 | EP0426824A1 Method for the preparation of active ingredients and pharmaceutical compositions for decorporating radioactive isotopes from living organisms |
| 05/08/1991 | EP0426504A1 Detoxification of certain environmental protection agency declared toxicants by naturally occurring anaerobic organisms |
| 05/07/1991 | US5013863 Learning enhancement |
| 05/07/1991 | US5013570 Method of producing odorless ripe juice of houttuynia cordata |
| 05/02/1991 | EP0424437A1 Recombinant mycobacterial expression vehicles and uses therefor |
| 04/24/1991 | EP0423325A1 Use of cobalt to enhance urinary copper excretion |
| 04/24/1991 | CA2009238A1 Detoxification of certain environmental protection agency declared toxicants by naturally occurring anaerobic organisms |
| 04/23/1991 | US5010092 Protection against chemically-induced kidney damage by methimazole |
| 04/18/1991 | WO1991005552A1 Method and compositions for inhibition of disorders associated with oxidative damage |
| 03/26/1991 | US5003098 Administering a Myo-Inositol Triphosphate |
| 03/20/1991 | EP0417238A1 Silicon-containing environment-protective agent adsorbing radioactive metal isotopes and toxic heavy metals and a pharmaceutical composition containing same. |
| 03/13/1991 | EP0416855A2 Fatty acids for the treatment and prevention of skin damage caused by radiotherapy |
| 03/08/1991 | CA2024724A1 Fatty acid therapy |
| 02/27/1991 | CN1049499A 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(rs)- derivatives with properties of mucus-adjustment and antiischemia |
| 02/26/1991 | US4996318 Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke |
| 02/26/1991 | US4996235 3,4-diphenylbutanamines |
| 02/20/1991 | EP0413668A2 New 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(RS)-substitutes, useful as antioxidizing pharmaceutical products having mucoregolating and anti-ischemic properties |
| 02/19/1991 | CA2023522A1 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(rs)-substitutes, useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties |
| 02/19/1991 | CA1280371C Botulinum toxin neutralizer |
| 01/30/1991 | EP0409845A1 Method for protection from chemotherapeutic side effects |
| 01/29/1991 | US4988701 Cyclic amino-thioacetal amides, a process for the preparation thereof and pharmaceutical compositions |
| 01/29/1991 | CA1279646C 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same |
| 01/23/1991 | EP0409499A2 Pharmaceutical compositions |
| 01/23/1991 | EP0409410A1 Indenoindole compounds |
| 01/22/1991 | US4987123 L-alanine and l-glutamine or salts or peptides thereof |
| 01/16/1991 | EP0408384A1 N,N'-dicarboxymethyl, N,N'-dicarbamoylmethyl diaminoalkane derivatives and their use in pharmaceutical compositions. |
| 01/14/1991 | WO1991000854A1 N,n'-dicarboxymethyl, n,n'-diaminocarbonylmethyl-diaminoalkane derivatives and their use in pharmaceutical compositions |
| 01/14/1991 | WO1991000729A2 Bis-dioxopiperazines, and their use as protecting agents |
| 01/14/1991 | CA2033203A1 Pharmaceutical compositions |
| 01/14/1991 | CA2033192A1 Pharmaceutical compositions |
| 01/08/1991 | US4983604 Inhibitors of nonenzymatic cross-linking |
| 01/02/1991 | EP0405506A1 Tetrapeptide type-B CCK receptor ligands |
| 12/31/1990 | CA2020065A1 Tetrapeptide type-b cck receptor ligands |
| 12/23/1990 | WO1990015799A1 Indenoindole compounds ii |
| 12/23/1990 | CA2060897A1 Indenoindole compounds ii |
| 12/19/1990 | EP0403090A1 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasopastic disease |
| 12/18/1990 | CA1277914C Use of dopamine agonists |
| 12/15/1990 | WO1990015610A1 A composition for removing or inactivating harmful components in blood or other extracellular body fluids |
| 12/15/1990 | CA2058442A1 Composition for removing or inactivating harmful components in blood or other extracellular body fluids |
| 12/12/1990 | CA2016466A1 7-oxabicycloheptane imidozole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| 12/05/1990 | EP0377739A4 Method of obtaining n-allyl-2-pyridinaldoxime bromide |
| 11/27/1990 | US4973586 Antidepressant, analgesics, hypotensive agent |
| 11/25/1990 | WO1990014343A1 Method for the preparation of active ingredients and pharmaceutical compositions for decorporating radioactive isotopes from living organisms |
| 11/25/1990 | CA2033188A1 Method for the preparation of active ingredients and pharmaceutical compositions for decorporating radioactive isotopoes from living organisms |
| 11/22/1990 | EP0398525A1 Compositions, containing inositol phosphate, preparation and uses |
| 11/13/1990 | CA1276151C Amides and esters of 2-¬-n-(hydroxypiperidinoalkyl) and (hydroxypyrrolidinoalkyl)-aminosulfonyl|-6-nitrobenzoic acids useful as adjuncts to radiation therapy |
| 10/30/1990 | US4966774 Antiinflammtory agents, a remedy for cardiac disorder, storage stability |
| 10/24/1990 | EP0368972A4 Method of safely providing anesthesia or conscious sedation |